Berenberg Bank Reiterates “Buy” Rating for Craneware (LON:CRW)

Craneware (LON:CRW)‘s stock had its “buy” rating restated by Berenberg Bank in a research note issued on Tuesday, Digital Look reports. They presently have a GBX 2,600 ($32.89) price objective on the stock. Berenberg Bank’s target price suggests a potential upside of 10.26% from the company’s previous close.

Craneware Trading Up 2.1 %

CRW stock opened at GBX 2,358 ($29.83) on Tuesday. Craneware has a 52 week low of GBX 1,290 ($16.32) and a 52 week high of GBX 2,509.20 ($31.74). The company has a market capitalization of £832.85 million, a PE ratio of 11,285.24 and a beta of 0.14. The company’s 50-day simple moving average is GBX 2,290.41 and its 200 day simple moving average is GBX 2,135.65. The company has a debt-to-equity ratio of 19.15, a quick ratio of 1.00 and a current ratio of 0.78.

About Craneware

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.